Study demonstrates that Paxlovid protects severe COVID-19–associated outcomes among persons for whom it is recommended

By | November 24, 2022
Researchers assessed the association between receiving a prescription for Paxlovid and COVID-19-related hospitalization in the ensuing 30 days.